Evidence map›Paper›PMID 21712494›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2011

Role of sphingolipids in murine radiation-induced lung injury: protection by sphingosine 1-phosphate analogs.

Biji Mathew, Jeffrey R Jacobson, Evgeny Berdyshev, Yong Huang, Xiaoguang Sun, Yutong Zhao, Lynnette M Gerhold, Jessica Siegler, Carrie Evenoski, Ting Wang and 12 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 63 citations in OpenAlex.

  1. eNAMPT Is a Novel DAMP and Therapeutic Target in Human and Murine Pulmonary Fibrosis.American journal of respiratory cell and molecular biology · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Involvement of eNAMPT/TLR4 signaling in murine radiation pneumonitis: protection by eNAMPT neutralization.Translational research : the journal of laboratory and clinical medicine · 2022
    Article
  11. Article
  12. MRSA-induced endothelial permeability and acute lung injury are attenuated by FTY720 S-phosphonate.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  13. Review
  14. My Journey in Academia as a Lipid Biochemist.Cell biochemistry and biophysics · 2021
    Review
  15. Lysophospholipids in Lung Inflammatory Diseases.Advances in experimental medicine and biology · 2021
    Article
  16. Article
  17. Review
  18. Frontiers in pharmacology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 1 country.

Biji MathewInstitute for Personalized Respiratory Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Jeffrey R Jacobson
Evgeny Berdyshev
Yong Huang
Xiaoguang Sun
Yutong Zhao
Lynnette M Gerhold
Jessica Siegler
Carrie Evenoski
Ting Wang
Tong Zhou
Rafe Zaidi
Liliana Moreno-Vinasco
Robert Bittman
Chin Tu Chen
Patrick J LaRiviere
Saad Sammani
Yves A Lussier
Steven M Dudek
Viswanathan Natarajan
Ralph R Weichselbaum
Joe G N Garcia
Erikson Institute · USUniversity of Chicago · USQueens College, CUNY · USUniversity of Illinois Chicago · US

Funding

Nation Center: Multi-Scale Study- Cellular Networks(RMI)U54CA121852 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2005 to 2015
$37.4M
Therapeutic Potential of FTY720 Analogues in Lung InjuryP01HL098050 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NATARAJAN, VISWANATHAN · 2011 to 2015
$10.9M
Synthesis of Novel Bioactive Sphingolipids as a ResourceR24HL083187 · NHLBI · QUEENS COLLEGE · PI BITTMAN, ROBERT · 2006 to 2013
$2.5M
Intracellular S1P &signaling in lung endothelial cellsR01HL079396 · NHLBI · UNIVERSITY OF CHICAGO · PI NATARAJAN, VISWANATHAN · 2005 to 2009
$1.8M
Tailored Algorithms for Non-Contrast Computed Tomography Using Sinogram RestoratiR01CA134680 · NCI · UNIVERSITY OF CHICAGO · PI LA RIVIERE, PATRICK JEAN · 2008 to 2013
$1.3M
Semantic Approaches to Phenotypic Databases AnalysesK22LM008308 · NLM · UNIVERSITY OF CHICAGO · PI LUSSIER, YVES A · 2004 to 2006
$468k
NCI NIH HHS 5U54CA121852-05NCI NIH HHS R01 CA134680NCI NIH HHS U54 CA121852NHLBI NIH HHS HL083187NHLBI NIH HHS HL09805NHLBI NIH HHS HL58094NHLBI NIH HHS P01 HL098050NHLBI NIH HHS R01 HL079396NHLBI NIH HHS R24 HL083187NLM NIH HHS K22 LM008308NLM NIH HHS K22 LM008308-04
6 · The paper itself

Abstract

Clinically significant radiation-induced lung injury (RILI) is a common toxicity in patients administered thoracic radiotherapy. Although the molecular etiology is poorly understood, we previously characterized a murine model of RILI in which alterations in lung barrier integrity surfaced as a potentially important pathobiological event and genome-wide lung gene mRNA levels identified dysregulation of sphingolipid metabolic pathway genes. We hypothesized that sphingolipid signaling components serve as modulators and novel therapeutic targets of RILI. Sphingolipid involvement in murine RILI was confirmed by radiation-induced increases in lung expression of sphingosine kinase (SphK) isoforms 1 and 2 and increases in the ratio of ceramide to sphingosine 1-phosphate (S1P) and dihydro-S1P (DHS1P) levels in plasma, bronchoalveolar lavage fluid, and lung tissue. Mice with a targeted deletion of SphK1 (SphK1(-/-)) or with reduced expression of S1P receptors (S1PR1(+/-), S1PR2(-/-), and S1PR3(-/-)) exhibited marked RILI susceptibility. Finally, studies of 3 potent vascular barrier-protective S1P analogs, FTY720, (S)-FTY720-phosphonate (fTyS), and SEW-2871, identified significant RILI attenuation and radiation-induced gene dysregulation by the phosphonate analog, fTyS (0.1 and 1 mg/kg i.p., 2×/wk) and to a lesser degree by SEW-2871 (1 mg/kg i.p., 2×/wk), compared with those in controls. These results support the targeting of S1P signaling as a novel therapeutic strategy in RILI.

Indexed as

Radiation Injuries, ExperimentalAnimalsBronchoalveolar Lavage FluidCeramidesFemaleGene DeletionGene Expression RegulationLungLysophospholipidsMiceMice, Inbred C57BLMice, KnockoutReceptors, LysosphingolipidSphingolipidsSphingosineCeramidesLysophospholipidsReceptors, LysosphingolipidSphingolipidsSphingosinesphingosine 1-phosphate

Identifiers

PMID21712494
PMCPMC3177585
OpenAlexW2157870467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.